Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 23%
Buy 15%
Hold 54%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services has demonstrated a positive financial outlook, highlighted by a 190 basis points expansion in the Acute Care Services segment's same-store adjusted EBITDA margin to 15.8%. The company reported a 12.8% increase in same-store revenue for the acute segment, with a notable rise in revenue per adjusted admission by 9.8%, suggesting robust operational performance and patient engagement. Additionally, with pending CMS program approvals that could yield a $75-80 million benefit and a favorable 2026 outlook driven by strong pricing power, Universal Health Services appears well-positioned for sustained revenue growth.

Bears say

The analysis of Universal Health Services Inc reveals a negative outlook primarily due to anticipated volume and margin headwinds, with earnings projected to be approximately 5% below previous estimates for fiscal year 2026, resulting in a reduced enterprise multiple averaging 5.5x—indicative of trough levels. Furthermore, the company's long-term growth projections for its behavioral health segment have been lowered to a growth rate of 2-3%, alongside a forecasted decline in the DPP contribution to EBITDA starting in 2028, with potential financial impacts estimated between $420-470 million from 2028 to 2032. Additionally, external risks including regulatory changes, market concentration in Las Vegas, and labor supply constraints further threaten the productivity and profitability of the firm's operations.

UHS has been analyzed by 13 analysts, with a consensus rating of Hold. 23% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 13 analysts, UHS has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $232.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $232.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.